UTI vs STRA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

UTI

46.2
AI Score
VS
UTI Wins

STRA

44.7
AI Score

Investment Advisor Scores

UTI

46score
Recommendation
HOLD

STRA

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric UTI STRA Winner
Revenue 661.15M 643.19M UTI
Net Income 15.54M 69.97M STRA
Net Margin 2.4% 10.9% STRA
Operating Income 19.27M 91.56M STRA
ROE 4.5% 4.3% UTI
ROA 1.7% 3.4% STRA
Total Assets 897.86M 2.07B STRA
Cash 130.06M 123.75M UTI
Current Ratio 1.30 1.10 UTI
Free Cash Flow -63.50M 92.35M STRA

Relative Price Performance (Last 90 Days)

UTI 1M: +6.1% · 3M: -42.7% STRA 1M: +4.3% · 3M: +7.9%

Current Technical Phase

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.4 · Price: $21.66

STRA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.8 · Price: $81.59

Fundamentals Snapshot

Metric UTI STRA
Market Cap — —
Forward P/E 29.5 9.7
Trailing P/E 34.1 13.3
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.6% 0.5%
Operating Margin 0.0% 0.2%
EPS 0.61 5.99
Dividend Yield — 0.03%

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.